Alterations in the Gut Microbiota and Metabolite Profiles of Lung Cancer Patients
Current Microbiology · 2025
DOI: 10.1007/s00284-025-04362-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Microbiology, 2025. Verfasst von Nan Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Zhongda Hospital of Southeast University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Gastrointestinal Microbiome, Bacteria, Metabolome. Die Arbeit nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China Youth Foundation, Open Project of Zhenjiang Traditional Chinese Medicine Spleen and Stomach Disease Clinical Medicine Research Center, Zhongda Hospital Affliated to Southeas University.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Lung cancer is the leading cause of cancer-related deaths worldwide. The gut microbiota is known to be involved in the occurrence and development of a variety of cancers, but the role of gut microbiota in lung cancer remains unclear. Here, we selected fecal samples of lung cancer patients and healthy people for 16S rRNA high-throughput sequencing and untargeted metabolomics analysis, respectively. The results showed that Actinobacteria, Proteobacteria, Patescibacteria, Cyanobacteria and Verrucomicrobiota were enriched in the LC; And the interaction between bacteria in the LC was more complicated than that in the NC. ROC showed that Actinobacteriota, Bacteroidota, Verrucomicrobiota and 7 kinds of bacteria at the genus have a better resolution for LC There are 82 kinds of metabolites that were different between NC and LC, mainly lipid metabolism molecules KEGG analysis indicated that Glycerophospholipid metabolism and alpha-Linolenic acid metabolism may be different in the LC and NC. ROC showed that 15 kinds of metabolites had a better classification effect on LC and NC; And we found that the correlation between metabolites in NC was higher than that in LC. This article pointed out the direction for follow-up research on its role in the occurrence and development of lung cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Zhongda Hospital of Southeast University, Nanjing, 210009, China.
- Medical School, Southeast University, Nanjing, 210009, China.
- Zhenjiang Hospital Affiliated to Nanjing University of Chinese Medicine, Zhenjiang, 212000, China.
- Zhenjiang Traditional Chinese Medicine Spleen and Stomach Disease Clinical Medicine Research Center, Zhenjiang, 212000, China.
- Department of Respiratory Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, 210001, China.
- Department of Oncology, Zhongda Hospital of Southeast University, Nanjing, 210009, China. zhengshiya1990@163.com.
Förderung
- National Natural Science Foundation of China Youth Foundation
- Open Project of Zhenjiang Traditional Chinese Medicine Spleen and Stomach Disease Clinical Medicine Research Center
- Zhongda Hospital Affliated to Southeas University
Zitieren
APA
Li, N., Qian, Q., Ouyang, J., Hu, M., Chang, L., & Zheng, S. (2025). Alterations in the Gut Microbiota and Metabolite Profiles of Lung Cancer Patients. Current Microbiology. https://doi.org/10.1007/s00284-025-04362-3
Vancouver
Li N, Qian Q, Ouyang J, Hu M, Chang L, Zheng S. Alterations in the Gut Microbiota and Metabolite Profiles of Lung Cancer Patients. Current Microbiology. 2025. doi:10.1007/s00284-025-04362-3
BibTeX
@article{Li2025,
author = {Li, Nan and Qian, Qiliu and Ouyang, Jun and Hu, Mingyue and Chang, Ligong and Zheng, Shiya},
title = {Alterations in the Gut Microbiota and Metabolite Profiles of Lung Cancer Patients},
journal = {Current Microbiology},
year = {2025},
doi = {10.1007/s00284-025-04362-3}
}
EUVIMED